At the time of writing, Foghorn Therapeutics Inc [FHTX] stock is trading at $8.28, up 4.94%. An important factor to consider is whether the stock is rising or falling in short-term value. The FHTX shares have gain 3.37% over the last week, with a monthly amount glided 27.19%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Foghorn Therapeutics Inc [NASDAQ: FHTX] stock has seen the most recent analyst activity on August 19, 2024, when Evercore ISI initiated its Outperform rating and assigned the stock a price target of $20. Previously, BofA Securities started tracking the stock with Buy rating on March 28, 2023, and set its price target to $10. On January 05, 2023, BMO Capital Markets initiated with a Outperform rating and assigned a price target of $20 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $25 on November 22, 2021. Wedbush initiated its recommendation with a Outperform and recommended $24 as its price target on November 17, 2020. Morgan Stanley started tracking with a Overweight rating for this stock on November 17, 2020, and assigned it a price target of $24. In a note dated November 17, 2020, Goldman initiated an Buy rating and provided a target price of $27 on this stock.
For the past year, the stock price of Foghorn Therapeutics Inc fluctuated between $2.70 and $8.50. Currently, Wall Street analysts expect the stock to reach $18 within the next 12 months. Foghorn Therapeutics Inc [NASDAQ: FHTX] shares were valued at $8.28 at the most recent close of the market. An investor can expect a potential return of 117.39% based on the average FHTX price forecast.
Analyzing the FHTX fundamentals
According to Foghorn Therapeutics Inc [NASDAQ:FHTX], the company’s sales were 35.19M for trailing twelve months, which represents an 23.02% jump. Gross Profit Margin for this corporation currently stands at 0.9% with Operating Profit Margin at -2.7%, Pretax Profit Margin comes in at -2.38%, and Net Profit Margin reading is -2.46%. To continue investigating profitability, this company’s Return on Assets is posted at -0.26, Equity is 1.4 and Total Capital is -0.34. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-2.86.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.87 points at the first support level, and at 7.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.50, and for the 2nd resistance point, it is at 8.71.
Ratios To Look Out For
It is important to note that Foghorn Therapeutics Inc [NASDAQ:FHTX] has a current ratio of 5.69. On the other hand, the Quick Ratio is 5.69, and the Cash Ratio is 2.73. Considering the valuation of this stock, the price to sales ratio is 13.02.
Transactions by insiders
Recent insider trading involved Cavalie Fanny, Chief Strategy/Bus Ops Officer, that happened on Mar 11 ’24 when 11000.0 shares were sold.
